| 12486312 |
Immunomodulatory proteins with tunable affinities |
Michael Kornacker |
2025-12-02 |
|
| 12421288 |
Interferon alpha-2 variants |
Emily Engelhart, Davis Goodnight, Kyle Minch |
2025-09-23 |
|
| 12358969 |
CTLA-4 variant immunomodulatory proteins and uses thereof |
Lawrence Evans, Joseph L. Kuijper |
2025-07-15 |
|
| 12297253 |
Multi-domain immunomodulatory proteins and methods of use thereof |
— |
2025-05-13 |
|
| 12281147 |
Interleukin 21 variants |
Davis Goodnight, Emily Engelhart |
2025-04-22 |
|
| 12110339 |
ICOS ligand variant immunomodulatory proteins and uses thereof |
Michael Kornacker |
2024-10-08 |
|
| 12065476 |
PD-1 variant immunomodulatory proteins and uses thereof |
Daniel William DEMONTE |
2024-08-20 |
|
| 11834490 |
CD112 variant immunomodulatory proteins and uses thereof |
Michael Kornacker, Daniel William DEMONTE, Mark F. Maurer, Dan ARDOUREL, Joseph L. Kuijper |
2023-12-05 |
$16,430,000 |
| 11753458 |
CTLA-4 variant immunomodulatory proteins and uses thereof |
Lawrence Evans, Joseph L. Kuijper |
2023-09-12 |
$8,298,000 |
| 11732022 |
PD-L2 variant immunomodulatory proteins and uses thereof |
Michael Kornacker, Mark F. Maurer, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. Kuijper |
2023-08-22 |
$9,022,000 |
| 11639375 |
CD80 variant immunomodulatory proteins and uses thereof |
Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper |
2023-05-02 |
$4,669,000 |
| 11613566 |
Variant ICOS ligand immunomodulatory proteins and related compositions and methods |
Lawrence Evans, Michael Kornacker |
2023-03-28 |
$4,826,000 |
| 11498967 |
CD80 variant immunomodulatory proteins and uses thereof |
Michael Kornacker |
2022-11-15 |
$4,578,000 |
| 11479609 |
CD80 variant immunomodulatory proteins and uses thereof |
Michael Kornacker |
2022-10-25 |
$3,739,000 |
| 11471488 |
CD155 variant immunomodulatory proteins and uses thereof |
Michael Kornacker, Daniel William DEMONTE, Mark F. Maurer |
2022-10-18 |
$4,172,000 |
| 11459370 |
BTNL3 proteins, nucleic acids and antibodies and uses thereof |
Heather A. Arnett, Sabine S. Escobar, Joanne L. Viney |
2022-10-04 |
$169,212,000 |
| 11359022 |
CD80 variant immunomodulatory proteins and uses thereof |
Michael Kornacker |
2022-06-14 |
$4,159,000 |
| 11319359 |
Immunomodulatory proteins with tunable affinities |
Michael Kornacker |
2022-05-03 |
$4,512,000 |
| 11230588 |
CD80 variant immunomodulatory proteins and uses thereof |
Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper |
2022-01-25 |
$4,204,000 |
| 11117949 |
CD80 variant immunomodulatory proteins and uses thereof |
Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper |
2021-09-14 |
$1,252,000 |
| 11117948 |
CD80 variant immunomodulatory proteins and uses thereof |
Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper |
2021-09-14 |
$1,252,000 |
| 11117950 |
CD80 variant immunomodulatory proteins and uses thereof |
Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper |
2021-09-14 |
$1,252,000 |
| 11096988 |
CD80 variant immunomodulatory proteins and uses thereof |
Michael Kornacker, Mark F. Maurer, Joseph L. Kuijper |
2021-08-24 |
$3,624,000 |
| 11078282 |
CD80 variant immunomodulatory proteins and uses thereof |
Michael Kornacker |
2021-08-03 |
$3,358,000 |
| 10882914 |
ICOS ligand variant immunomodulatory proteins and uses thereof |
Michael Kornacker |
2021-01-05 |
$12,352,000 |